Arterra Bioscience SpA ( (IT:ARBS) ) has provided an update.
The Ordinary Shareholders’ Meeting of Arterra Bioscience S.p.A. approved the financial statements for 2024, showing a 6.37% increase in production value and a 24.21% rise in net results compared to 2023. The meeting also appointed a new Board of Directors for 2025-2027, with Maria Gabriella Colucci confirmed as President, indicating a stable leadership structure for the company.
More about Arterra Bioscience SpA
Arterra Bioscience S.p.A. is a green biotech company focused on research and development in biotechnology. It has been listed on the Euronext Growth Milan market of Borsa Italiana S.p.A. since 2019.
YTD Price Performance: 21.43%
Average Trading Volume: 12,611
Technical Sentiment Signal: Sell
Current Market Cap: €15.85M
See more insights into ARBS stock on TipRanks’ Stock Analysis page.